Sign in with Google. Opens in new tab
ENTITY
Amgen Inc

Amgen Inc (AMGN US)

173
Analysis
Health CareUnited States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
bullishAmgen Inc
15 May 2024 18:00

Amgen Inc.: Will The Increased Spending on Research and Development (R&D) Pay Off? - Major Drivers

Amgen Inc. witnessed strong growth in the Q1 of 2024 with total revenue increasing by 22% YoY. This was largely driven by strong volume growth,...

Logo
249 Views
Share
19 Feb 2024 01:30

Kyowa Kirin (4151 JP): Recent Portfolio Strengthening Initiatives to Accelerate Long-Term Growth

​Kyowa Kirin partners with Bridgebio for infigratinib in Japan and enrolls first patient in Phase 2 trial for tivozanib eye drop for DME. Higher...

Logo
382 Views
Share
bullishAmgen Inc
15 Feb 2024 21:00

Amgen Inc: An Analysis Of The Pipeline Progress and Development! - Major Drivers

Amgen's Fourth Quarter 2023 Financial Results Conference Call highlighted several strategic moves and positive outcomes for the biotechnology...

Logo
260 Views
Share
bullishAmgen Inc
01 Dec 2023 00:07

Amgen Inc.: Expansion Of Oncology Research & Other Major Drivers

Amgen delivered a mixed set of results for the previous quarter, with revenues well below analyst expectations but managed earnings beat. The...

Logo
323 Views
Share
bullishAmgen Inc
23 Sep 2023 06:00

Amgen Inc.: Which New Medicines Became Their Growth Powerhouses? - Major Drivers

Amgen managed to exceed the revenue and earnings expectations of Wall Street, instilling confidence in its capacity for sustained long-term growth...

Logo
345 Views
Share
x